Skip to main content Accessibility help
×
Hostname: page-component-848d4c4894-ttngx Total loading time: 0 Render date: 2024-04-30T10:42:33.113Z Has data issue: false hasContentIssue false

23 - Autoimmune diseases

from Section 5 - Other disorders

Published online by Cambridge University Press:  19 October 2009

Caroline Grange
Affiliation:
Consultant, Anaesthetist, Nuffield Department of Anaesthetics, The John Radcliffe Hospital, Oxford, UK
David R. Gambling
Affiliation:
University of California, San Diego
M. Joanne Douglas
Affiliation:
University of British Columbia, Vancouver
Robert S. F. McKay
Affiliation:
University of Kansas
Get access

Summary

Introduction

An autoimmune disease represents a pathological condition caused by an immune response directed against an antigen within the body of the host. The most accepted theory suggests that autoimmunity results from a failure of the normal regulation of the immune system (which contains many immune cells that recognize self antigens, but are normally suppressed). The exact etiology of these diseases remains unclear, although there are a number of factors that are implicated in their development, including infection, hormonal effect, drug exposure, and human leukocyte antigen (HLA) type. The incidence and activity of autoimmune diseases are particularly high in young women and hence their occurrence in parturients is not uncommon. During pregnancy, mother and fetus produce immunological factors to limit cell-mediated immunity and prevent fetal rejection, but the high estrogen environment may enhance immune function resulting in these demographic findings.

Rheumatoid arthritis

Rheumatoid arthritis (RA) is a chronic systemic disorder characterized by symmetrical polyarthritis, resulting in joint destruction and deformity. Diagnosis depends on an aggregation of clinical symptoms, signs, laboratory data, and radiological data (see Table 23.1). The joints primarily affected include the wrists, knees, shoulders, and metacarpal-phalangeal joints, with frequent sparing of the larger joints and spinal column. However, RA is a multisystem disease and extra-articular manifestations include lymphadenopathy, fatigue, anemia, weight loss, interstitial lung disease, pericarditis, subcutaneous nodules (rheumatoid nodules), vasculitis, neuropathy, renal disease, Sjögren syndrome (parotid and lacrimal hypertrophy, keratoconjunctivitis, vaginitis, xerostomia), and Felty syndrome (see Table 23.2).

Type
Chapter
Information
Publisher: Cambridge University Press
Print publication year: 2008

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Ware Branch, D. & Flint Porter, T. Autoimmune disease. In James, D. K., Steer, P. J., Weiner, C. P. & Gonik, B. (eds.), High Risk Pregnancy: Management Options. London: W. B. Saunders, 1999.
Lawrence, R. C., Helmick, C. G., Arnett, F. C.et al. Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum. 1998; 41: 778–99.3.0.CO;2-V>CrossRefGoogle Scholar
Masi, A. T.Incidence of rheumatoid arthritis: do the observed age–sex interaction patterns support a role of androgenic-anabolic steroid deficiency in its pathogenesis?Br. J. Rheumatol. 1994; 33: 697–9.CrossRefGoogle Scholar
Ansar-Ahmed, S., Dauphinee, M. J. & Talal, N.Effects of short term administration of sex hormones on normal and autoimmune mice. J. Immunol. 1985; 134: 204–10.Google Scholar
Takagi, H., Ishiguro, N., Iwata, H. & Kanamono, T.Genetic association between rheumatoid arthritis and estrogen microsatellite polymorphisms. J. Rheumatol. 2000; 27: 1638–42.Google Scholar
Criswell, L. A., Merlino, L. A., Cerhan, J. R.et al. Cigarette smoking and the risk of rheumatoid arthritis among postmenopausal women: results from the Iowa Women's Health Study. Am. J. Med. 2002; 112: 465–71.CrossRefGoogle Scholar
Karlson, E. W., Mandl, L. A., Hankinson, S. E. & Grodstein, F.Do breast feeding and other reproductive factors influence future risk of rheumatoid arthritis? Results from the Nurses' Health Study. Arthritis Rheum. 2004; 50: 3458–67.Google Scholar
Spector, T. D., Hart, D. J. & Powell, R. J.Prevalence of rheumatoid arthritis and rheumatoid factor in women: evidence of a secular decline. Ann. Rheum. Dis. 1993; 52: 254–7.Google Scholar
Nelson, J. L. Rheumatoid arthritis. In Lee, R. V., Rosene-Montella, K, Barbour, L. A., Garner, P. R. & Keely, E. (eds.), Medical Care of the Pregnant Patient. Philadelphia: American College of Physicians, 2000.
Silman, A. J., Kay, A. & Brennan, P.Timing of pregnancy in relation to the onset of rheumatoid arthritis. Arthritis Rheum. 1992; 35: 152–5.CrossRefGoogle Scholar
Nelson, J. L. & Ostensen, M.Pregnancy and rheumatoid arthritis. Rheum. Dis. Clin. North Am. 1997; 23: 195–212.Google Scholar
Barrett, J. H., Brennan, P., Fiddler, M. & Silman, A. J.Does rheumatoid arthritis remit during pregnancy and relapse postpartum? Results from a nationwide study in the United Kingdom prospectively from late pregnancy. Arthritis Rheum. 1999; 42: 1219–27.3.0.CO;2-G>CrossRefGoogle Scholar
Cecere, F. A. & Persellin, R. H.The interaction of pregnancy and the rheumatoid diseases. Clin. Rheum. Dis. 1981; 7: 747–68.Google Scholar
Zurier, R. B.Pregnancy in patients with rheumatic diseases. Rheum. Dis. Clin. North Am. 1989; 15: 193–405.Google Scholar
Persellin, R. H.The effect of pregnancy on rheumatoid arthritis. Bull. Rheum. Dis. 1976–1977; 27: 922–7.Google Scholar
Brennan, P. & Silman, A. J.Breast-feeding and the onset of rheumatoid arthritis. Arthritis Rheum. 1994; 37; 808–13.Google Scholar
Brun, J. G., Nilssen, S. & Kvale, G.Breast-feeding, other reproductive factors and rheumatoid arthritis: a prospective study. Br. J. Rheumatol. 1995; 34: 542–6.CrossRefGoogle Scholar
Klipple, G. L. & Cecere, F. A.Rheumatoid arthritis and pregnancy. Rheum. Dis. Clin. North Am. 1989; 15: 213–39.Google Scholar
Yoshino, S. & Uchida, S.Sexual problems of women with rheumatoid arthritis. Arch. Phys. Med. Rehabil. 1981; 62: 122–3.Google Scholar
Branch, D. W.Pregnancy in patients with rheumatic diseases: obstetric management and monitoring. Lupus 2004; 13: 696–8.Google Scholar
Kaplan, D. & Diamond, H.Rheumatoid arthritis and pregnancy. Clin. Obstet. Gynecol. 1965; 8: 286–303.Google Scholar
Janssen, N. M. & Genta, M. S.The effects of immunosuppressive and anti-inflammatory medications on fertility, pregnancy and lactation. Arch. Intern. Med. 2000; 160: 610–19.Google Scholar
Ostensen, M.Safety on nonsteroidal anti-inflammatory drugs during pregnancy and lactation. Immunopharmacology 1996; 4: 31–41.Google Scholar
Soscia, P. N. & Zurier, R. B.Antirheumatic drug therapy during pregnancy. Bull. Rheum. Dis. 1997; 46: 2–4.Google Scholar
Committee on Drugs, American Academy of Pediatrics. The transfer of drugs and other chemicals into human breast milk. Pediatrics 1994; 93: 137–50.
Park-Wyllie, L., Mazzotta, P. I., Pastuszak, A.et al. Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta-analysis of epidemiological studies. Teratology 2000; 62: 385–92.Google Scholar
Petri, M.Immunosuppressive drug use in pregnancy. Autoimmunity 2003; 36: 51–6.Google Scholar
Alstead, E. M., Ritchie, J. K., Lennard-Jones, J. E., Farthing, M. J. & Clark, M. L.Safety of azathioprine in pregnancy in inflammatory bowel disease. Gastroenterology 1990; 99: 443–6.Google Scholar
Miehle, W.Current aspects of D-penicillamine and pregnancy. Z. Rheumatol. 1988; 47: 20–3.Google Scholar
Zeldis, J. B.Pregnancy and inflammatory bowel disease. West. J. Med. 1989; 151: 168–71.Google Scholar
Buchanan, N. M., Toubi, E., Khamashta, M. A.et al. Hydroxychloroquine and lupus pregnancy: review of a series of 36 cases. Am. Rheum. Dis. 1996; 55: 486–8.Google Scholar
Fiddler, M. A.Rheumatoid arthritis and pregnancy: issues for consideration in clinical management. Arthritis Care Res. 1997; 10: 264–72.CrossRefGoogle Scholar
Friedman, R. J., Schiff, C. F. & Bromberg, J. S.Use of supplemental steroids in patients having orthopaedic operations. J. Bone Joint Surg. Am. 1995; 77: 1801–6.Google Scholar
MacArthur, A. & Kleiman, S.Rheumatoid cervical joint disease: a challenge to the anaesthetist. Can. J. Anaesth. 1993; 40: 154–9.Google Scholar
Marks, J. D. & Bogetz, M. S.New concepts in the management of the difficult airway. Clin. Anesth. Update 1994; 5: 1–11Google Scholar
Conlon, P. W., Isdale, I. C. & Rose, B. S.Rheumatoid arthritis of the cervical spine. An analysis of 333 cases. Ann. Rheum. Dis. 1966; 25: 120–6.Google Scholar
Neva, M. H., Isomaki, P., Hannonen, P.et al. Early and extensive erosiveness in peripheral joints predicts atlantoaxial subluxations in patients with rheumatoid arthritis. J. Rheum. 2003; 48: 1808–13.Google Scholar
Fujiwara, K., Fujimoto, M., Owaki, H.et al. Cervical lesions related to the systemic progression in rheumatoid arthritis. Spine 1998; 23: 2052–6.Google Scholar
Boden, S. D., Dodge, L. D., Bohlman, H. H. & Rechtine, G. R.Rheumatoid arthritis of the cervical spine. A long term analysis with predictors of paralysis and recovery. J. Bone Joint Surg. Am. 1993; 75: 1282–97.Google Scholar
Takenaka, I., Urakami, Y., Aoyama, K.et al. Severe subluxation in the sniffing position in a rheumatoid patient with anterior atlantoaxial subluxation. Anesthesiology 2004; 101: 1235–7.Google Scholar
Campbell, R. S. D., Wou, P. & Watt, I.A continuing role for preoperative cervical spine radiography in rheumatoid arthritis?Clin. Radiol. 1995: 50: 157–9.Google Scholar
Hale, J. M. & Moriarty, D C.Perioperative evaluation of the cervical spine in rheumatoid arthritis using the dynamic magnetic resonance imaging. Br. J. Anaesth. 2001; 86: 148–9.Google Scholar
Practical guidelines for the management of the difficult airway. An updated report by the American Society of Anesthesiologists Task Force on Management of the Difficult Airway. Anesthesiology 2003; 98: 1269–77.
Wilson, M. E., Spiegelhalter, D., Robertson, J. A. & Lesser, P.Predicting difficult intubation. Br. J. Anaesth. 1988; 61: 211–16.CrossRefGoogle Scholar
Lofgren, R. H. & Montgomery, W. W.Incidence of laryngeal involvement in rheumatoid arthritis. N. Engl. J. Med. 1962; 267: 193–5.Google Scholar
Absalom, A. R., Watts, R. & Kong, A.Airway obstruction caused by rheumatoid cricoarytenoid arthritis. Lancet 1998; 351: 1099–100.Google Scholar
Kolman, J. & Morris, I.Cricoarytenoid arthritis: a cause of acute upper airway obstruction in rheumatoid arthritis. Can. J. Anesth. 2002; 49: 729–32.Google Scholar
Popat, M. T., Chippa, J. H. & Russell, R.Awake fibreoptic intubation following failed regional anaesthesia for Caesarean section in a parturient with Still's disease. Eur. J. Anaesthesiol. 2002; 17: 211–14.Google Scholar
Creed, F. & Ash, D.Depression in rheumatoid arthritis: aetiology and treatment. Int. Rev. Psychiatry 1992; 4: 23–34.Google Scholar
Lahita, R. G.The role of sex hormones in systemic lupus erythematosus. Curr. Opin. Rheumatol. 1999; 11: 352–6.Google Scholar
Tan, E. M., Cohen, A. S., Fries, J. F. et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982; 25: 1271–7.CrossRefGoogle Scholar
Hochberg, M. C.Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997; 40: 1725.CrossRefGoogle Scholar
Friedman, S. A., Bernstein, M. S. & Kitzmiller, J. L.Pregnancy complicated by collagen vascular disease. Obstet. Gynecol. Clin. North Am. 1991; 18: 213–36.Google Scholar
Toloza, S. M., Roseman, J. M., Alarcon, G. S.et al. Systemic lupus erythematosus in a multiethnic US cohort (LUMINA): XXII: Predictors of time to the occurrence of the initial damage. Arthritis Rheum. 2004; 50: 3177–86.CrossRefGoogle Scholar
Stoll, T., Sutcliffe, N., Mach, J.et al. Analysis of the relationship between disease activity and damage in patients with systemic lupus erythematosus – a 5 year prospective study. Rheumatology 2004; 43: 1039–44.Google Scholar
Swaak, A. J., Nossent, J. C. & Smeenk, R. J.Prognostic factors in systemic lupus erythematosus. Rheumatol. Int. 1991; 11: 127–32.Google Scholar
Tincani, A., Balestrieri, G., Faden, D. & DiMario, C.Systemic lupus erythematosus in pregnancy. Lancet 1991; 338: 756–7.Google Scholar
Petri, M., Howard, D. & Repke, J.Frequency of lupus flare in pregnancy: The Hopkins Lupus Pregnancy Center experience. Arthritis Rheum. 1991; 34: 1538–45.CrossRefGoogle Scholar
Riuz-Irastorza, G., Lima, F. & Alves, J.et al. Increased rate of lupus flare during pregnancy: a prospective study of 78 pregnancies. Br. J. Rheumatol. 1996; 35: 133–8.Google Scholar
Urowitz, M. B., Gladman, D. D. & Farewell, V. T.et al. Lupus and pregnancy studies. Arthritis Rheum. 1993; 36: 1392–7.CrossRefGoogle Scholar
Georgiou, P. E., Politi, E. N., Katsimbri, P., Sakka, V. & Drosos, A. A.Outcome of lupus pregnancy: a controlled study. Rheumatology 2000; 39: 1014–19.Google Scholar
Molad, Y., Borkowski, T., Monselise, A.et al. Maternal and fetal outcome of lupus pregnancy: a prospective study of 29 pregnancies. Lupus 2005; 14: 145–51.Google Scholar
Hayslett, J. P.Maternal and fetal complications in pregnant women with systemic lupus erythematosus. Am. J. Kidney Dis. 1991; 17: 123–6.CrossRefGoogle Scholar
Varner, M. W.Autoimmune disorders and pregnancy. Semin. Perinatol. 1991; 15: 238–50.Google Scholar
Julkunen, H., Kaaja, R., Palosuo, T., Gronhagen-Riska, C. & Teramo, K.Pregnancy in lupus nephropathy. Acta Obstet. Gynecol. Scand. 1993: 72: 258–63.Google Scholar
Khamashta, M. A. & Hughes, G. R. V.Pregnancy in systemic lupus erythematosus. Curr. Opin. Rheumatol. 1996; 8: 424–9.Google Scholar
Mok, C. C. & Wong, R. W. S.Pregnancy in systemic lupus erythematosus. Postgrad. Med. J. 2001; 77: 157–65.Google Scholar
Mok, C. C., Lau, C. S. & Wong, R. W. S.Risk factors or ovarian failure in patients with systemic lupus erythematosus receiving cyclophosphamide therapy. Arthritis Rheum. 1998; 41: 831–7.3.0.CO;2-1>CrossRefGoogle Scholar
Chakravarty, E. F., Colon, I., Langen, E. S.et al. Factors that predict prematurity and pre-eclampsia in pregnancies that are complicated by systemic lupus erythematosus. Am. J. Obstet. Gynecol. 2005; 192: 1897–904.Google Scholar
Raj, R., Murin, S., Matthay, R. A. & Wiedemann, H. P.Systemic lupus erythematosus in the intensive care. Crit. Care Clin. 2002; 18: 781–803.Google Scholar
Keane, M. P., Ven, C. J. M., Lynch, J. P. III & McCune, W. J.Systemic lupus during pregnancy with refractory alveolar haemorrhage: recovery following termination during pregnancy. Lupus 1997; 6: 730–3.Google Scholar
Melk, A., Mueller-Eckhardt, G., Polten, B.et al. Diagnostic and prognostic significance of anticardiolipin antibodies in patients with recurrent spontaneous abortions. Am. J. Reprod. Immunol. 1995; 33: 228–33.Google Scholar
Clowse, M. E. B., Magder, L. S., Witter, F. & Petri, M.The impact of increased lupus activity on obstetric outcomes. Arthritis Rheum. 2005; 52: 514–21.CrossRefGoogle Scholar
Petri, M.Prospective study of systemic lupus erythematosus pregnancies. Lupus 2004; 13: 688–9.Google Scholar
Ross, G., Nas, R. & Lockshin, M.Effects of mothers' autoimmune disease during pregnancy on learning disabilities and hand preference in children. Arch. Pediatr. Adolesc. Med. 2003; 157: 397–402.Google Scholar
Buyon, J. P.Neonatal lupus syndromes. Curr. Opin. Rheumatol. 1994; 6: 523–9.Google Scholar
Lee, L. A.Maternal autoantibodies and pregnancy–II: the neonatal lupus syndrome. Baillieres Clin. Rheumatol. 1990; 4: 69–84.Google Scholar
McCune, A. B., Weston, W. L. & Lee, L. AMaternal and fetal outcome in neonatal lupus erythematosus. Ann. Intern. Med. 1987; 106: 518–23.Google Scholar
Cimaz, R., Spence, D. L., Hornberger, L. & Silverman, E. D.Incidence and spectrum of neonatal lupus erythematosus: a prospective study of infants born to mothers with anti-Ro autoantibodies. J. Pediatr. 2003; 142: 678–83.CrossRefGoogle Scholar
Jaeggi, E. T., Hamilton, R. M., Silverman, E. D., Zamoras, A. & Hornberger, L. K.Outcome of children with fetal, neonatal or childhood diagnosis of isolated congenital atrioventricular block. A single institution's experience of 30 years. J. Am. Coll. Cardiol. 2002; 39: 130–7.Google Scholar
Rosenthal, D., Druzin, M., Chin, C.et al. A new therapeutic approach to the fetus with congenital complete heart block: preemptive targeted therapy with dexamethasone. Obstet. Gynecol. 1998; 92: 689–91.Google Scholar
Riuz-Irastorza, G. & Khamashta, M. A.Evaluation of systemic lupus erythematosus activity during pregnancy. Lupus 2004; 13: 679–82.Google Scholar
LeBlanc, Walz B. A., Gladman, D. D. & Urowitz, M. B.Serologically active clinically quiescent systemic lupus erythematosus predictors of clinical flares. J. Rheumatol. 1994; 21: 2239–41.Google Scholar
Petri, M.Systemic lupus erythematosus: women's health care issues. Bull. Rheum. Dis. 2001; 49: 1–3.Google Scholar
Mandell, B. F.Cardiovascular involvement in systemic lupus erythematosus. Semin. Arthritis Rheum. 1987; 17: 126–41.CrossRefGoogle Scholar
Nihoyannopoulos, P., Gomez, P. M., Joshi, J.et al. Cardiac abnormalities in systemic lupus erythematosus. Association with raised anticardiolipin abnormalities. Circulation 1990; 82: 369–75.Google Scholar
Roldan, C. A., Shively, B. K. & Crawford, M. H.An echocardiographic study of valvular heart disease associated with systemic lupus erythematosus. N. Engl. J. Med. 1996; 335: 1424–30.Google Scholar
Carette, S.Cardiopulmonary manifestations of systemic lupus erythematosus. Rheum. Dis. Clin. North Am. 1988; 14: 135–47.Google Scholar
Petri, M., Perez-Gutthann, S., Spence, D. & Hochberg, M. C.Risk factors for coronary artery disease in patients with systemic lupus erythematosus. Am. J. Med. 1992; 93: 513–19.CrossRefGoogle Scholar
Robinson, D. R. Systemic lupus erythematosus. In Dale, D. C., Federman, D. D., Antman, K.et al. (eds.), Scientific American Medicine, Vol. 2. New York: WedMD Professional Publishing, 1999.
Omdal, R., Henriksen, O. A., Mellgren, S. I. & Husby, G.Peripheral neuropathy in systemic lupus erythematosus. Neurology 1991; 41: 808–11.Google Scholar
Mikdashi, J., Krumholz, A. & Handwerger, B.Factors at diagnosis predict subsequent occurrence of seizures in systemic lupus erythematosus. Neurology 2005; 64: 2102–7.Google Scholar
Winslow, T. M., Ossipov, M. A., Fazio, G. P.et al. Five year follow-up study of the prevalence and progression of pulmonary hypertension in systemic lupus erythematosus. Am. Heart J. 1995; 129: 510–15.CrossRefGoogle Scholar
Cuenco, J., Tzeng, G. & Wittels, B.Anesthetic management of the parturient with systemic lupus erythematosus, pulmonary hypertension and pulmonary edema. Anesthesiology 1999; 91: 568–70.Google Scholar
Keeling, D. M. & Isenberg, D. A.Haematological manifestations of SLE. Blood Rev. 1993; 7: 199–207.CrossRefGoogle Scholar
Pitkin, R. M.Polyarteritis nodosa. Clin. Obstet. Gynecol. 1983; 26: 579–86.Google Scholar
Carpenter, M. T. & West, S. G.Polyarteritis nodosa in hairy cell leukaemia: treatment with interferon-alpha. J. Rheumatol. 1994; 21: 1150–2.Google Scholar
Guillevin, L., Lhote, F., Cohen, P.et al. Polyarteritis nodosa related hepatitis B virus. A prospective study with short term observation of 41 patients. Medicine 1995; 74: 238–53.Google Scholar
Lhote, F. & Guillevin, L.Polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome. Clinical aspects and treatment. Rheum. Dis. Clin. North Am. 1995; 21: 911–43.Google Scholar
Lightfoot, R. W., Michet, B. A., Bloch, D. A.et al. The American College of Rheumatology 1990 criteria for the classification of polyarteritis nodosa. Arthritis Rheum. 1990; 33: 1088–93.CrossRefGoogle Scholar
Gayraud, M., Guillevin, L., Toumelin, P.et al. Long term follow up of polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome. analysis of four prospective trials including 278 patients. Arthritis Rheum. 2001; 44: 666–75.3.0.CO;2-A>CrossRefGoogle Scholar
Guillevin, L., Cohen, P., Mahr, A.et al. Treatment of polyarteritis nodosa and microscopic polyangiitis with poor prognostic factors: a prospective trial comparing glucocorticoids and six or twelve cyclophosphamide pulses in sixty-five patients. Arthritis Rheum. 2003; 49: 93–100.CrossRefGoogle Scholar
Frohnert, P. P. & Sheps, S. G.Long term follow up study of periarteritis nodosa. Am. J. Med. 1967; 43: 8–14.CrossRefGoogle Scholar
Guillevin, L., Lhote, F., Gayraud, M.et al. Prognostic features in polyarteritis nodosa and Churg-Strauss syndrome. A prospective study in 342 patients. Medicine 1996; 75: 17–28.Google Scholar
Ramsey-Goldman, R.The effect of pregnancy on the vasculitides. Scand. J. Rheumatol. Suppl. 1998; 107: 116–17.Google Scholar
Stone, M. S., Olson, R. R., Weismann, D. N.et al. Cutaneous vasculitis in the newborn of a mother with cutaneous polyarteritis nodosa. J. Am. Acad. Dermatol. 1993; 28: 101–5.Google Scholar
Black, C. M.Scleroderma-clinical aspects. J. Intern. Med. 1993; 234: 115–18.Google Scholar
Anonymous. Systemic sclerosis: current pathogenetic concepts and future prospects for target therapy. Lancet 1996; 347: 1453–8.
Janosik, D. L., Osborn, T. G., Moore, T. L.et al. Heart disease in systemic sclerosis. Semin. Arthritis Rheum. 1989; 19: 191–200.CrossRefGoogle Scholar
Seibold, J. R., Korn, J. H., Simms, R.et al. Recombinant human relaxin in the treatment of scleroderma. Ann. Intern. Med. 2000; 132: 871–9.Google Scholar
Ferri, C., Valentini, G., Cozzi, F.et al. Systemic sclerosis: demographic, clinical and serologic features and survival in 1,012 Italian patients. Medicine 2002; 81: 139–53.Google Scholar
Scussel-Lonzetti, L., Joyal, F., Raynauld, J. P.et al. Predicting mortality in systemic sclerosis: analysis of a cohort of 309 French Canadian patients with emphasis on features at diagnosis as predictive factors for survival. Medicine 2002; 81: 154–67.Google Scholar
Rothfield, N., Kurtzman, S., Vazquez–Abad, D.et al. Association of anti-topoisomerase I with cancer. Arthritis Rheum. 1992; 35: 724.CrossRefGoogle Scholar
Englert, H., Brennan, P., McNeil, D.et al. Reproductive function prior to disease onset in women with scleroderma. J. Rheumatol. 1992; 19: 1575–9.Google Scholar
Steen, V. D., Conte, C., Day, N.et al. Pregnancy in women with systemic sclerosis. Arthritis Rheum. 1989; 32: 151–7.CrossRefGoogle Scholar
Chin, K. A. J., Kaseba, C. M. & Weaver, J. B.Scleroderma in pregnancy. J. Obstet. Gynaecol. 1998; 18: 238–42.Google Scholar
Steen, V. D.Pregnancy in women with systemic sclerosis. Obstet. Gynecol. 1999; 94: 15–20.Google Scholar
Steen, V. D.Scleroderma and pregnancy. Rheum. Dis. Clin. North Am. 1997; 23: 133–47.Google Scholar
Baethge, B. A. & Wolf, R. E.Successful pregnancy with scleroderma renal disease and pulmonary hypertension in a patient using angiotensin converting enzyme inhibitors. Ann. Rheum. Dis. 1989; 48: 776–8.Google Scholar
Silman, A. J. & Black, C.Increased incidence of spontaneous abortion and infertility in women with scleroderma before disease onset: a case controlled study. Ann. Rheum. Dis. 1988; 47: 441–4.Google Scholar
Steen, V. D. & Medsger, T. A.Fertility and pregnancy outcome in women with systemic sclerosis. Arthritis Rheum. 1999; 42: 763–8.3.0.CO;2-V>CrossRefGoogle Scholar
Moore, M., Saffran, J. E., Baraf, H. S. & Jacobs, R. P.Systemic sclerosis and pregnancy complicated by obstructive uropathy. Am. J. Obstet. Gynecol. 1985; 153: 893–4.Google Scholar
Bellucci, M. J., Coustan, D. R. & Plotz, R. D.Cervical scleroderma: a case of soft tissue dystocia. Am. J. Obstet. Gynecol. 1984; 150: 891–2.Google Scholar
Thompson, J. & Conklin, K. A.Anesthetic management of a pregnant patient with scleroderma. Anesthesiology 1983; 59: 69–71.Google Scholar
Younker, D. & Harrison, B.Scleroderma and pregnancy: anaesthetic considerations. Br. J. Anaesth. 1985; 57: 1136–9.CrossRefGoogle Scholar
Eisele, J. H. & Reitan, J. A.Scleroderma, Raynaud's phenomenon, and local anesthesics. Anesthesiology 1971; 34: 386–7.Google Scholar
Bailey, A. R., Wolmarans, M. & Rhodes, S.Spinal anaesthesia for caesarean section in a patient with systemic sclerosis. Anaesthesia 1999; 54: 355–8.Google Scholar
Lewis, G. B.Prolonged regional analgesia in scleroderma. Can. Anaesth. Soc. J. 1974; 21: 495–7.Google Scholar
Neill, R. S.Progressive systemic sclerosis. Prolonged sensory blockade following regional anaesthesia in association with a reduced response to systemic analgesics. Br. J. Anaesth. 1980; 52: 623–5.CrossRefGoogle Scholar
Hseu, S. S., Sung, C. S., Mao, C. C., Tsai, S. K. & Lee, T. K.Anesthetic management in a parturient with progressive systemic sclerosis during caesarean section – a case report. Acta Anaesthesiol. Sin. 1997; 35: 161–6.Google Scholar
D'Angelo, R. & Miller, R.Pregnancy complicated by severe preeclampsia and thrombocytopenia in a patient with scleroderma. Anesth. Analg. 1997; 85: 839–41.Google Scholar
Sammaritano, L. R.Antiphospholipid syndrome: review. South. Med. J. 2005; 98: 617–25.Google Scholar
Cervera, R., Piette, J. C., Font, J.et al. Antiphospholipid syndrome: clinical and immunological manifestation and patterns of disease expression in a cohort of 1000 patients. Arthritis Rheum. 2002; 46: 1019–27.CrossRefGoogle Scholar
Carp, H. J. A.Antiphospholipid syndrome in pregnancy. Curr. Opin. Obstet. Gynecol. 2004; 16: 129–35.Google Scholar
Sebastiani, G. D., Galeazzi, M., Tincani, A.et al. Anticardiolipin and anti–beta2GPI antibodies in a large series of European patients with systemic lupus erythematosus. Prevalence and clinical associations. European concerted action on immunogenetics of SLE. Scand. J. Rheumatol. 1999; 28: 344–51.Google Scholar
Sammaritano, L. R., Ng, S., Sobel, R.et al. Anticardiolipin IgG subclasses. Association of IgG2 with arterial and/or venous thrombosis. Arthritis Rheum. 1997; 40: 1998–2006.CrossRefGoogle Scholar
Parke, A.Short and long term maternal outcomes in patients with phospholipid antibodies. Lupus 2004; 13: 703–4.Google Scholar
Erkan, D., Asherson, R. A., Espinosa, G.et al. Long term outcome of catastrophic syndrome survivors. Ann. Rheum. Dis. 2003; 62: 530–3.Google Scholar
Asherson, R. A., Cervera, R., Piette, J. C.et al. Catastrophic antiphospholipid syndrome: clinical and laboratory features of 50 patients. Medicine 1998; 77: 195–207.Google Scholar
Kutteh, W. H.Antiphospholipid antibodies and reproduction. J. Reprod. Immunol. 1997; 35: 151–71.Google Scholar
Vinatier, D., Dufour, P., Cosson, M.et al. Antiphospholipid syndrome and recurrent miscarriages. Eur. J. Obst. Gynecol. Reprod. Biol. 2001; 96: 37–50.Google Scholar
Blank, M. & Shoenfeld, Y.Antiphosphatidylserine antibodies and reproductive failure. Lupus 2004; 13: 731–5.Google Scholar
Branch, D. W.Antiphospholipid antibodies and fetal compromise. Thrombosis Research 2004; 114: 415–18.Google Scholar
Derksen, R. H. W. M., Khamashta, M. A. & Branch, D. W.Management of the obstetric antiphospholipid syndrome. Arthritis Rheum. 2004; 50: 1028–39.CrossRefGoogle Scholar
Lassere, M. & Empson, M.Treatment of antiphospholipid syndrome in pregnancy – a systematic review of randomized therapeutic trials. Thrombosis Research 2004; 114: 419–26.Google Scholar
Ringrose, D. K.Anaesthesia and the antiphospholipid syndrome: a review of 20 obstetric patients. Int. J. Obstet. Anesth. 1997; 6: 107–11.Google Scholar
Ralph, C. J.Anaesthetic management of parturients with the antiphospholipid syndrome: a review of 27 cases. Int. J. Obstet. Anesth. 1999; 8: 249–52.Google Scholar
Rawat, R. S. & Dehran, M.Anaesthetic management of a pregnant patient with antiphospholipid antibody syndrome for emergency caesarean section. Int. J. Obstet. Anesth. 2003; 12: 311.Google Scholar
Ihle, B. U. & Oziemski, P.Multiorgan failure secondary to catastrophic anti-phospholipid syndrome. Anaesth. Intensive Care 2002; 30: 82–5.Google Scholar
Dorman, R. I. P.Acute postoperative biventricular failure associated with antiphospholipid antibody syndrome. Br. J. Anaesth. 2004; 92: 748–54.Google Scholar
Ozaki, M., Ogata, M., Yokoyama, T.et al. Prevention of thrombosis with prostaglandin E1 in a patient with catastrophic antiphospholipid syndrome. Can. J. Anesth. 2005; 52: 143–7.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

  • Autoimmune diseases
    • By Caroline Grange, Consultant, Anaesthetist, Nuffield Department of Anaesthetics, The John Radcliffe Hospital, Oxford, UK
  • Edited by David R. Gambling, University of California, San Diego, M. Joanne Douglas, University of British Columbia, Vancouver, Robert S. F. McKay, University of Kansas
  • Book: Obstetric Anesthesia and Uncommon Disorders
  • Online publication: 19 October 2009
  • Chapter DOI: https://doi.org/10.1017/CBO9780511544552.024
Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

  • Autoimmune diseases
    • By Caroline Grange, Consultant, Anaesthetist, Nuffield Department of Anaesthetics, The John Radcliffe Hospital, Oxford, UK
  • Edited by David R. Gambling, University of California, San Diego, M. Joanne Douglas, University of British Columbia, Vancouver, Robert S. F. McKay, University of Kansas
  • Book: Obstetric Anesthesia and Uncommon Disorders
  • Online publication: 19 October 2009
  • Chapter DOI: https://doi.org/10.1017/CBO9780511544552.024
Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

  • Autoimmune diseases
    • By Caroline Grange, Consultant, Anaesthetist, Nuffield Department of Anaesthetics, The John Radcliffe Hospital, Oxford, UK
  • Edited by David R. Gambling, University of California, San Diego, M. Joanne Douglas, University of British Columbia, Vancouver, Robert S. F. McKay, University of Kansas
  • Book: Obstetric Anesthesia and Uncommon Disorders
  • Online publication: 19 October 2009
  • Chapter DOI: https://doi.org/10.1017/CBO9780511544552.024
Available formats
×